Ngā hua rapu - Schlageter, Marie Hélène

Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy mā Blanchard, Pierre, Quero, Laurent, Pacault, Vincent, Schlageter, Marie-Helene, Baruch-Hennequin, Valerie, Hennequin, Christophe

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses mā Maslah, Nabih, Soret, Juliette, Dosquet, Christine, Vercellino, Laetitia, Belkhodja, Célia, Schlageter, Marie-Hélène, Cassinat, Bruno, Kiladjian, Jean-Jacques, Chomienne, Christine, Giraudier, Stephane

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine: The First European Experience mā Balay, Marie Alix, Aidan, Patrick, Schlageter, Marie Helene, Georges, Odette, Meas, Taly, Bechara, Maroun, Toubert, Marie Elisabeth, Faugeron, Isabelle, Monpeyssen, Herve, Chougnet, Cécile N.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements mā Drevon, Louis, Maslah, Nabih, Soret-Dulphy, Juliette, Dosquet, Christine, Ravdan, Odno, Vercellino, Laetitia, Belkhodja, Celia, Parquet, Nathalie, Brignier, Anne C., Schlageter, Marie-Helene, Cassinat, Bruno, Kiladjian, Jean-Jacques, Chomienne, Christine, Giraudier, Stéphane

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Synergistic effects of PRIMA-1(Met) (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia mā Maslah, Nabih, Salomao, Norman, Drevon, Louis, Verger, Emmanuelle, Partouche, Nicolas, Ly, Pierre, Aubin, Philippe, Naoui, Nadia, Schlageter, Marie-Helene, Bally, Cecile, Miekoutima, Elsa, Rahmé, Ramy, Lehmann-Che, Jacqueline, Ades, Lionel, Fenaux, Pierre, Cassinat, Bruno, Giraudier, Stephane

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Ruxolitinib before allogeneic hematopoietic transplantation in patients with myelofibrosis on behalf SFGM-TC and FIM groups mā Robin, Marie, Porcher, Raphael, Orvain, Corentin, Bay, Jacques-Olivier, Barraco, Fiorenza, Huynh, Anne, Charbonnier, Amandine, Forcade, Edouard, Chantepie, Sylvain, Bulabois, Claude, Yakoub-Agha, Ibrahim, Detrait, Marie, Michonneau, David, Turlure, Pascal, Raus, Nicole, Boyer, Françoise, Suarez, Felipe, Vincent, Laure, Guyen, Stéphanie N., Cornillon, Jérôme, Villate, Alban, Dupriez, Brigitte, Cassinat, Bruno, Rolland, Valérie, Schlageter, Marie Hélène, Socié, Gérard, Kiladjian, Jean-Jacques

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

The folate cycle enzyme MTHFR is a critical regulator of cell response to MYC-targeting therapies. mā Su, Angela, Ling, Frank, Vaganay, Camille, Sodaro, Gaetano, Benaksas, Chaïma, Bello, Reinaldo Dal, Forget, Antoine, Pardieu, Bryann, Lin, Kevin H., Rutter, Justine C., Bassil, Christopher F., Fortin, Gael, Pasanisi, Justine, Antony-Debré, Iléana, Alexe, Gabriela, Benoist, Jean-François, Pruvost, Alain, Pikman, Yana, Qi, Jun, Schlageter, Marie-Hélène, Micol, Jean-Baptiste, Roti, Giovanni, Cluzeau, Thomas, Dombret, Hervé, Preudhomme, Claude, Fenouille, Nina, Benajiba, Lina, Golan, Hava M., Stegmaier, Kimberly, Lobry, Camille, Wood, Kris C., Itzykson, Raphael, Puissant, Alexandre

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa